Production of glycosylated physiologically "normal" human alpha 1-antitrypsin by mouse fibroblasts modified by insertion of a human alpha 1-antitrypsin cDNA using a retroviral vector.
about
Challenges and Prospects for Alpha-1 Antitrypsin Deficiency Gene TherapyAn alternative approach to somatic cell gene therapy.High-level expression of biologically active human alpha 1-antitrypsin in the milk of transgenic miceImproved gene expression upon transfer of the adenosine deaminase minigene outside the transcriptional unit of a retroviral vector.Alpha 1-antitrypsin deficiency caused by the alpha 1-antitrypsin Nullmattawa gene. An insertion mutation rendering the alpha 1-antitrypsin gene incapable of producing alpha 1-antitrypsinSite-specific enzymatic polysialylation of therapeutic proteins using bacterial enzymesRetroviruses as genetic tools to isolate transcriptionally active chromosomal regions.Improvement of avian leukosis virus (ALV)-based retrovirus vectors by using different cis-acting sequences from ALVsMolecular basis of alpha 1-antitrypsin deficiency and emphysema associated with the alpha 1-antitrypsin Mmineral springs allele.Gene therapy approaches for stem cell protection.Therapeutic levels of human protein C in rats after retroviral vector-mediated hepatic gene therapy.Adenovirus: the first effective in vivo gene delivery vectorPulmonary cell biology.Expression of human alpha 1-antitrypsin using a recombinant adenovirus vector.Long-term expression of human alpha1-antitrypsin gene in mouse liver achieved by intravenous administration of plasmid DNA using a hydrodynamics-based procedure.Proteolytic and N-glycan processing of human α1-antitrypsin expressed in Nicotiana benthamiana
P2860
Q28080450-D4431378-E482-4175-B0C1-B398A172334EQ33571138-8F83FCA8-FF53-466A-8171-298C54B445F7Q33672151-E0CB2552-9FA5-417C-92C3-FB10F00FC4ECQ33856071-EDA9CECB-BF34-46F9-8B46-E174D17BFCF7Q34570030-190F4D85-7FEA-4F99-B6F1-A01CAEFAF097Q34938414-452AF160-7C34-4E37-8AC9-94D9B3EC1E1FQ35034076-69DF2B6E-506F-4D57-AEA7-40DAB31EFCFCQ36696130-4309D190-0959-4087-9BF3-ADFCA6ECBE81Q36712966-7B218682-3365-4CD2-9FA9-3B6B0BCB2CEDQ36911194-112AD36B-A571-42D2-8419-080E02AB1061Q37383736-AA2D58AA-DAF6-4BF7-BEC8-A9ECE8409E75Q37508260-15FB40A7-1EFB-4AED-85B1-12202AA112A4Q41752319-46CE680A-39B9-439A-B278-172A5C6E6BD7Q44357326-B4E87AB2-DC6E-4A14-BAD2-68C2DB3F5E19Q45869678-2FB92AD1-53FB-4B83-A348-E2B43D7CC308Q56974439-CC07FF73-96FB-4AB6-892E-EF5225AD270F
P2860
Production of glycosylated physiologically "normal" human alpha 1-antitrypsin by mouse fibroblasts modified by insertion of a human alpha 1-antitrypsin cDNA using a retroviral vector.
description
1987 nî lūn-bûn
@nan
1987 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
name
Production of glycosylated phy ...... DNA using a retroviral vector.
@ast
Production of glycosylated phy ...... DNA using a retroviral vector.
@en
Production of glycosylated phy ...... DNA using a retroviral vector.
@nl
type
label
Production of glycosylated phy ...... DNA using a retroviral vector.
@ast
Production of glycosylated phy ...... DNA using a retroviral vector.
@en
Production of glycosylated phy ...... DNA using a retroviral vector.
@nl
prefLabel
Production of glycosylated phy ...... DNA using a retroviral vector.
@ast
Production of glycosylated phy ...... DNA using a retroviral vector.
@en
Production of glycosylated phy ...... DNA using a retroviral vector.
@nl
P2093
P2860
P356
P1476
Production of glycosylated phy ...... DNA using a retroviral vector.
@en
P2093
Anderson WF
Brantly ML
Courtney M
Crystal RG
Garver RI Jr
Karlsson S
Nienhuis AW
P2860
P304
P356
10.1073/PNAS.84.4.1050
P407
P577
1987-02-01T00:00:00Z